Xyosted 100 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FCFDR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,254
Award facts
- Contract value 100% obligated
- $1,253.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,253.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector units. The contract, issued on September 19, 2025, with completion targeted for September 22, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). This IDC, valued at $999.999 billion through December 2026, serves as a comprehensive global pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The award involved no set-aside designation and was competitively awarded through firm fixed pricing.
XYOSTED is a testosterone replacement therapy product delivered via auto-injector, critical for treating hypogonadism in military personnel and veterans. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary distribution and logistics operations. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through its extensive portfolio of specialty medications, brand-name and generic drugs, and medical devices, demonstrating its established capability to meet federal medical procurement requirements across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FCFDR?
SPE2DB25FCFDR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FCFDR worth?
The government has obligated $1,254 on SPE2DB25FCFDR.
Is contract SPE2DB25FCFDR an order under another contract?
Yes. SPE2DB25FCFDR is a delivery order under SPE2DB24D1006, an indefinite delivery contract.
Was contract SPE2DB25FCFDR competed?
The extent of competition for SPE2DB25FCFDR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award